Head to Head Comparison: ZimVie (NASDAQ:ZIMV) & Item 9 Labs (OTC:INLB)

Item 9 Labs (OTC:INLBGet Rating) and ZimVie (NASDAQ:ZIMVGet Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.


This table compares Item 9 Labs and ZimVie’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Item 9 Labs -52.53% -11.86% -9.82%
ZimVie N/A N/A N/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Item 9 Labs and ZimVie, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Item 9 Labs 0 0 1 0 3.00
ZimVie 1 1 0 0 1.50

Item 9 Labs presently has a consensus price target of $4.00, indicating a potential upside of 300.00%. Given Item 9 Labs’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Item 9 Labs is more favorable than ZimVie.

Valuation & Earnings

This table compares Item 9 Labs and ZimVie’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Item 9 Labs $21.94 million 4.33 -$10.91 million ($0.16) -6.25
ZimVie $1.01 billion 0.57 -$95.30 million N/A N/A

Item 9 Labs has higher earnings, but lower revenue than ZimVie.

Institutional & Insider Ownership

19.4% of ZimVie shares are held by institutional investors. 19.8% of Item 9 Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.


Item 9 Labs beats ZimVie on 6 of the 11 factors compared between the two stocks.

Item 9 Labs Company Profile (Get Rating)

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

ZimVie Company Profile (Get Rating)

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.